GR66544B - - Google Patents
Info
- Publication number
- GR66544B GR66544B GR57080A GR780157080A GR66544B GR 66544 B GR66544 B GR 66544B GR 57080 A GR57080 A GR 57080A GR 780157080 A GR780157080 A GR 780157080A GR 66544 B GR66544 B GR 66544B
- Authority
- GR
- Greece
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3591277 | 1977-08-26 | ||
| GB398378 | 1978-02-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR66544B true GR66544B (ko) | 1981-03-26 |
Family
ID=26238729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR57080A GR66544B (ko) | 1977-08-26 | 1978-08-25 |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU523536B2 (ko) |
| DK (1) | DK376078A (ko) |
| GR (1) | GR66544B (ko) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK151884C (da) * | 1979-03-07 | 1988-06-13 | Pfizer | Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf |
-
1978
- 1978-08-25 AU AU39281/78A patent/AU523536B2/en not_active Expired
- 1978-08-25 DK DK376078A patent/DK376078A/da not_active Application Discontinuation
- 1978-08-25 GR GR57080A patent/GR66544B/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU3928178A (en) | 1980-02-28 |
| AU523536B2 (en) | 1982-08-05 |
| DK376078A (da) | 1979-02-27 |